Hereditary angio-oedema in children: A management guideline

Pediatric Allergy and Immunology

Volumn 16, Issue 4, 2005, Pages 288-294

  Boyle, Robert J ^a,b   Nikpour, Mandana ^a   Tang, Mimi L K ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Child; Clinical protocol; Complement 1 inactivators; Drug therapy; Hereditary angio oedema

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; ANDROGEN; ANTIFIBRINOLYTIC AGENT; ANTIHISTAMINIC AGENT; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4; CONTRACEPTIVE AGENT; CORTICOSTEROID; DANAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KALLIKREIN; PLACEBO; PLASMIN; PLASMINOGEN; PREKALLIKREIN; STANOZOLOL; TRANEXAMIC ACID;

ANGIONEUROTIC EDEMA; CHILDHOOD MORTALITY; CLINICAL TRIAL; COLOR VISION DEFECT; CONSTIPATION; DEPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE SEVERITY; DIZZINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; GENE MUTATION; GROWTH RETARDATION; HEADACHE; HEALTH EDUCATION; HEPATITIS C; HEPATITIS G; HUMAN; HYPERTENSION; LIVER CELL CARCINOMA; LIVER DISEASE; MENARCHE; MUSCLE CRAMP; MUSCLE NECROSIS; MYOSITIS; NAUSEA; PLASMA TRANSFUSION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROPHYLAXIS; RASH; RETINA DEGENERATION; REVIEW; SIDE EFFECT; TACHYPHYLAXIS; THROMBOEMBOLISM; TREATMENT OUTCOME; TREATMENT PLANNING; VIRILIZATION; WEIGHT GAIN;

ADOLESCENT; ANGIONEUROTIC EDEMA; CHILD; HUMANS; PRACTICE GUIDELINES;

EID: 20944433272     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2005.00275.x     Document Type: Review

References (52)

1. STOPPA-LYONNET D, DUPONCHEL C, MEO T, et al. Recombinational biases in the rearranged C1-inhibitor genes of hereditary angioedema patients. Am J Hum Genet 1991; 49: 1055-62.
2. CICARDI M, BERGAMASCHINI L, MARASINI B, BOCCASSINI G, TUCCI A, AGOSTONI A. Hereditary angioedema: an appraisal of 104 cases. Am J Med Sci 1982; 284: 2-9.
3. AGOSTONI A, CICARDI M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992; 71: 206-15.
4. BINKLEY KE, DAVIS A 3rd. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 2000; 106: 546-50.
5. BORK K, BARNSTEDT SE, KOCH P, TRAUFE H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000; 356: 213-7.
6. FARKAS H, HARMAT G, FUST G, VARGA L, VISY B. Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol 2002; 13: 153-61.
7. BORK K, HARDT J, SCHICKETANZ KH, RESSEL N. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 2003; 163: 1229-35.
8. BOWEN T, CICARDI M, FARKAS H, et al. Canadian 2003 International Consensus Algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol 2004; 114: 629-37.
9. VERSTRAETE M. Clinical application of inhibitors of fibrinolysis. Drugs 1985; 29: 236-61.
10. NZEAKO UC, FRIGAS E, TREMAINE WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 2001; 161: 2417-29.
11. FRANK MM, SERGENT JS, KANE MA, ALLING DW. Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med 1972; 286: 808-12.
12. SHEER AL, AUSTEN KF, ROSEN FS. Tranexamic acid therapy in hereditary angioneurotic edema. N Engl J Med 1972; 287: 452-4.
13. GWYNN CM. Therapy in hereditary angioneurotic oedema. Arch Dis Child 1974; 49: 636-40.
14. CICARDI M, ZINGALE L. How do we treat patients with hereditary angioedema. Transfus Apheresis Sci 2003; 29: 221-7.
15. SHEER AL, FEARON DT, AUSTEN KF, ROSEN FS. Tranexamic acid: preoperative prophylactic therapy for patients with hereditary angioneurotic edema. J Allergy Clin Immunol 1977; 60: 38-40.
16. CROSHER R. Intravenous tranexamic acid in the management of hereditary angio-oedema. Br J Oral Maxillofac Surg 1987; 25: 500-6.
17. ABINUN M. Hereditary angio-oedema in children. Lancet 1999; 353: 2242.
18. DUNN CJ, GOA KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999; 57: 1005-32.
19. ENDO Y, NISHIMURA S, MIURA A. Deep-vein thrombosis induced by tranexamic acid in idiopathic thrombocytopenic purpura. JAMA 1988; 259: 3561-2.
20. KAVANAGH GM, SANSOM JE, HARRISON P, WARWICK JA, PEACHEY RD. Tranexamic acid (Cyklokapron)-induced fixed-drug eruption. Br J Dermatol 1993; 128: 229-30.
21. SNIR M, AXER-SIEGEL R, BUCKMAN G, YASSUR Y. Central venous stasis retinopathy following the use of tranexamic acid. Retina 1990; 10: 181-4.
22. PARSONS MR, MERRITT DR, RAMSAY RC. Retinal artery occlusion associated with tranexamic acid therapy. Am J Ophthalmol 1988; 105: 688-9.
23. KITAMURA H, MATSUI I, ITOH N, et al. Tranexamic acid-induced visual impairment in a hemodialysis patient. Clin Exp Nephrol 2003; 7: 311-4.
24. GELFAND JA, SHERINS RJ, ALLING DW, FRANK MM. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med 1976; 295: 1444-8.
25. ROTHBACH C, GREEN RL, LEVINE MI, FIREMAN P. Prophylaxis of attacks of hereditary angioedema. Am J Med 1979; 66: 681-3.
26. FARKAS H, HARMAT G, GYENEY L, FUST G, VARGA L. Danazol therapy for hereditary angio-oedema in children. Lancet 1999; 354: 1031-2.
27. RAJAGOPAL C. HARPER JR. Successful use of danazol for hereditary angio-oedema. Arch Dis Child 1981; 56: 229-30.
28. BARAKAT A, CASTALDO AJ. Hereditary angioedema: danazol therapy in a 5-year-old child. Am J Dis Child 1993; 147: 931-2.
29. FARKAS H, GYENEY L, GIDOFALVY E, FUST G, VARGA L. The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures. J Oral Maxillofac Surg 1999; 57: 404-8.
30. MAEDA S, MIYAWAKI T, NOMURA S, YAGI T, SHIMADA M. Management of oral surgery in patients with hereditary or acquired angioedemas: review and case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 540-3.
31. AGOSTONI A, AYGOREN-PURSUN E, BINKLEY KE, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004; 114 (Suppl. 3): S51-131.
32. BORK K, PITTON M, HARTEN P, KOCH P. Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema. Lancet 1999; 353: 1066-7.
33. CICARDI M, CASTELLI R, ZINGALE LC, AGOSTONI A. Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol 1997; 99: 194-6.
34. GADEK JE, HOSEA SW, GELFAND JA, et al. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N End J Med 1980; 302: 542-6.
35. BORK K, WITZKE G. Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency. J Allergy Clin Immunol 1989; 83: 677-82.
36. WAYTES AT, ROSEN FS, FRANK MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med 1996; 334: 1630-4.
37. MOHR M, POLLOK-KOPP B, GOTZE O, BURCHARDI H. The use of a C1-inhibior concentrate for short-term preoperative prophylaxis in two patients with hereditary angioedema. Anaesthesist 1996; 45: 626-30.
38. MAVES KK, WEILER JM. Tonsillectomy in a patient with hereditary angioedema after prophylaxis with C1 inhibitor concentrate. Ann Allergy 1994; 73: 435-8.
39. BORK K, BARNSTEDT SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med 2001; 161: 714-8.
40. KUNSCHAK M, ENGL W, MARITSCH F, et al. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema. Transfusion 1998; 38: 540-9.
41. CICARDI M, MANNUCCI PM, CASTELLI R, RUMI MG, AGOSTONI A. Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate. Transfusion 1995; 35: 209-12.
42. DE FILIPPI F, CASTELLI R, CICARDI M, et al. Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor. Transfusion 1998; 38: 307-11.
43. ATKINSON JC, FRANK MM. Oral manifestations and dental management of patients with hereditary angioedema. J Oral Pathol Med 1991; 20: 139-42.
44. TRACHSEL D, HAMMER J. A vote for inhaled adrenaline in the treatment of severe upper airway obstruction caused by piercing of the tongue in hereditary angioedema. Intensive Care Med 1999; 25: 1335-6.
45. BORK K, KOCH P. Episodes of severe dyspnea caused by snoring-induced recurrent edema of the soft palate in hereditary angioedema. J Am Acad Dermatol 2001; 45: 968-9.
46. FARKAS H, FUST G, FEKETE B, KARADI I, VARGA L. Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema. Lancet 2001; 358: 1695-6.
47. YIP J, CUNLIE WJ. Hormonally exacerbated hereditary angioedema. Australas J Dermatol 1992; 33: 35-8.
48. NIELSEN EW, JOHANSEN HT, HOLT J, MOLLNES TE. C1 inhibitor and diagnosis of hereditary angioedema in newborns. Pediatr Res 1994; 35: 184-7.
49. BORK K, BARNSTEDT SE. Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J Am Dent Assoc 2003; 134: 1088-94.
50. CARUGATI A, PAPPALARDO E, ZINGALE LC, CICARDI M. C1-inhibitor deficiency and angioedema. Mol Immunol 2001; 38: 161-73.
51. SHEER AL, FEARON DT, AUSTEN KF. Hereditary angioedema: a decade of management with stanozolol. J Allergy Clin Immunol 1987; 80: 855-60.
52. BORK K, SIEDLECKI K, BOSCH S, SCHOPF RE, KREUZ W. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 2000; 75: 349-54.